|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 451/04 | (2006.01) |
| A61K 31/46 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 1526134 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04004193.1 |
| Date of filing the European patent application | 2001-05-09 | |
| (97) | Date of publication of the European application | 2005-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2008-09-03 |
| (46) | Date of publication of the claims translation | 2009-01-26 |
| (30) | Number | Date | Country code |
| 0014046 | 2000-05-26 | GB | |
| 0015835 | 2000-06-27 | GB |
| (72) |
Perros, Manoussos, GB
Price, David Anthony, GB
Stammen, Blanda Luzia Christa, GB
Wood, Anthony, GB
|
| (73) |
Pfizer Limited,
Ramsgate Road, Sandwich, Kent CT13 9NJ,
GB
PHIVCO-1 LLC,, Corporation Service Company, 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808, US |
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Triazoliltropano dariniai kaip CCR5 moduliatoriai |
| TRIAZOLYL TROPANE DERIVATIVES AS CCR5 MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2020-04-29 | 347.00 EUR |